Using AI/ML & Multi-Omics to Determine Efficacy for Clinical NASH Study Enrichment: Highlights from Recently Completed Phase 2 Trials with Rencofilstat

Time: 11:00 am
day: Day 2 Seminar B Pre-Lunch Tracks


  • Use of AI/ML to enrich NASH clinical trials
  • Use of Multi-omics with ML for biomarker prediction
  • Use of AI/ML for NASH patient selection